These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 28623450

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Altered connectivity between striatal and extrastriatal regions in patients with schizophrenia on maintenance antipsychotics: an [18 F]fallypride PET and functional MRI study.
    Kim JH, Cumming P, Son YD, Kim HK, Joo YH, Kim JH.
    Synapse; 2018 Dec; 72(12):e22064. PubMed ID: 30063263
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nigrostriatal and Mesolimbic D2/3 Receptor Expression in Parkinson's Disease Patients with Compulsive Reward-Driven Behaviors.
    Stark AJ, Smith CT, Lin YC, Petersen KJ, Trujillo P, van Wouwe NC, Kang H, Donahue MJ, Kessler RM, Zald DH, Claassen DO.
    J Neurosci; 2018 Mar 28; 38(13):3230-3239. PubMed ID: 29483278
    [Abstract] [Full Text] [Related]

  • 9. Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography.
    Kegeles LS, Slifstein M, Xu X, Urban N, Thompson JL, Moadel T, Harkavy-Friedman JM, Gil R, Laruelle M, Abi-Dargham A.
    Biol Psychiatry; 2010 Oct 01; 68(7):634-41. PubMed ID: 20673873
    [Abstract] [Full Text] [Related]

  • 10. The role of striatal dopamine D2/3 receptors in cognitive performance in drug-free patients with schizophrenia.
    Veselinović T, Vernaleken I, Janouschek H, Cumming P, Paulzen M, Mottaghy FM, Gründer G.
    Psychopharmacology (Berl); 2018 Aug 01; 235(8):2221-2232. PubMed ID: 29717334
    [Abstract] [Full Text] [Related]

  • 11. [18F]fallypride characterization of striatal and extrastriatal D2/3 receptors in Parkinson's disease.
    Stark AJ, Smith CT, Petersen KJ, Trujillo P, van Wouwe NC, Donahue MJ, Kessler RM, Deutch AY, Zald DH, Claassen DO.
    Neuroimage Clin; 2018 Aug 01; 18():433-442. PubMed ID: 29541577
    [Abstract] [Full Text] [Related]

  • 12. Acute effect of intravenously applied alcohol in the human striatal and extrastriatal D2 /D3 dopamine system.
    Pfeifer P, Tüscher O, Buchholz HG, Gründer G, Vernaleken I, Paulzen M, Zimmermann US, Maus S, Lieb K, Eggermann T, Fehr C, Schreckenberger M.
    Addict Biol; 2017 Sep 01; 22(5):1449-1458. PubMed ID: 27396374
    [Abstract] [Full Text] [Related]

  • 13. Reduced D2/D3 Receptor Binding of Extrastriatal and Striatal Regions in Temporal Lobe Epilepsy.
    Bernedo Paredes VE, Buchholz HG, Gartenschläger M, Breimhorst M, Schreckenberger M, Werhahn KJ.
    PLoS One; 2015 Sep 01; 10(11):e0141098. PubMed ID: 26544593
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas.
    Vernaleken I, Janouschek H, Raptis M, Hellmann S, Veselinovic T, Bröcheler A, Boy C, Cumming P, Hiemke C, Rösch F, Schäfer WM, Gründer G.
    Int J Neuropsychopharmacol; 2010 Aug 01; 13(7):951-60. PubMed ID: 20392299
    [Abstract] [Full Text] [Related]

  • 18. The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride binding.
    Zald DH, Woodward ND, Cowan RL, Riccardi P, Ansari MS, Baldwin RM, Cowan RL, Smith CE, Hakyemez H, Li R, Kessler RM.
    Neuroimage; 2010 May 15; 51(1):53-62. PubMed ID: 20149883
    [Abstract] [Full Text] [Related]

  • 19. [18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholics.
    Rominger A, Cumming P, Xiong G, Koller G, Böning G, Wulff M, Zwergal A, Förster S, Reilhac A, Munk O, Soyka M, Wängler B, Bartenstein P, la Fougère C, Pogarell O.
    Addict Biol; 2012 Mar 15; 17(2):490-503. PubMed ID: 22023291
    [Abstract] [Full Text] [Related]

  • 20. Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study.
    Werhahn KJ, Landvogt C, Klimpe S, Buchholz HG, Yakushev I, Siessmeier T, Müller-Forell W, Piel M, Rösch F, Glaser M, Schreckenberger M, Bartenstein P.
    Epilepsia; 2006 Aug 15; 47(8):1392-6. PubMed ID: 16922886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.